rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-7
|
pubmed:abstractText |
The prognosis of glioblastoma multiforme remains poor despite recent therapeutic advances. Several clinical and therapeutic factors as well as tumour characteristics have been reported as significant to survival. A more efficient determination of the prognostic factors is required to optimize individual therapeutic management. The aim of our study was to evaluate by univariate then multivariate analysis the factors that influence prognosis and particularly survival.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0942-0940
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
149
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
245-52; discussion 252-3
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:17273889-Adolescent,
pubmed-meshheading:17273889-Adult,
pubmed-meshheading:17273889-Aged,
pubmed-meshheading:17273889-Aged, 80 and over,
pubmed-meshheading:17273889-Brain Neoplasms,
pubmed-meshheading:17273889-Chemotherapy, Adjuvant,
pubmed-meshheading:17273889-Combined Modality Therapy,
pubmed-meshheading:17273889-Cranial Irradiation,
pubmed-meshheading:17273889-Dacarbazine,
pubmed-meshheading:17273889-Disease-Free Survival,
pubmed-meshheading:17273889-Female,
pubmed-meshheading:17273889-Glioblastoma,
pubmed-meshheading:17273889-Humans,
pubmed-meshheading:17273889-Male,
pubmed-meshheading:17273889-Middle Aged,
pubmed-meshheading:17273889-Multivariate Analysis,
pubmed-meshheading:17273889-Neoplasm, Residual,
pubmed-meshheading:17273889-Prognosis,
pubmed-meshheading:17273889-Radiotherapy, Adjuvant,
pubmed-meshheading:17273889-Retrospective Studies
|
pubmed:year |
2007
|
pubmed:articleTitle |
Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients.
|
pubmed:affiliation |
Department of Neurosurgery, Hospital Roger Salengro, University Medical Centre, Lille, France. j-mineo@chru-lille.fr
|
pubmed:publicationType |
Journal Article
|